These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 3689962)
1. [N-methylcytisine--a selective ligand of nicotinic receptors of acetylcholine in the CNS]. Pliashkevich IuG; Demushkin VP Biull Eksp Biol Med; 1987 Dec; 104(12):690-2. PubMed ID: 3689962 [TBL] [Abstract][Full Text] [Related]
2. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine. Khan IM; Yaksh TL; Taylor P J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312 [TBL] [Abstract][Full Text] [Related]
3. [Structural characteristics of the recognition site of cholinergic ligands of the nicotinic acetylcholine receptor from squid optic ganglia]. Pliashkevich IuG; Demushkin VP Biokhimiia; 1985 Jul; 50(7):1167-74. PubMed ID: 4041496 [TBL] [Abstract][Full Text] [Related]
4. In vitro evidence and age-related changes for nicotinic but not muscarinic acetylcholine receptors in the central nervous system of Sepia officinalis. Bellanger C; Halm MP; Dauphin F; Chichery R Neurosci Lett; 2005 Oct; 387(3):162-7. PubMed ID: 16026931 [TBL] [Abstract][Full Text] [Related]
5. Identification of 9-fluoro substituted (-)-cytisine derivatives as ligands with high affinity for nicotinic receptors. Houllier N; Gopisetti J; Lestage P; Lasne MC; Rouden J Bioorg Med Chem Lett; 2010 Nov; 20(22):6667-70. PubMed ID: 20880707 [TBL] [Abstract][Full Text] [Related]
6. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445 [TBL] [Abstract][Full Text] [Related]
7. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Gopalakrishnan M; Molinari EJ; Sullivan JP Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615 [TBL] [Abstract][Full Text] [Related]
8. Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor. Carter CR; Cao L; Kawai H; Smith PA; Dryden WF; Raftery MA; Dunn SM Biochem Pharmacol; 2007 Feb; 73(3):417-26. PubMed ID: 17118342 [TBL] [Abstract][Full Text] [Related]
9. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins. Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328 [TBL] [Abstract][Full Text] [Related]
10. [Effect of nucleotides on N-methylcytisine and dimethyltubocurarine binding by the nicotinic acetylcholine receptors of the optic ganglia in the squid B. magister]. Pliashkevich IuG; Demushkin VP Biull Eksp Biol Med; 1989 Jun; 107(6):706-9. PubMed ID: 2790167 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes. Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687 [TBL] [Abstract][Full Text] [Related]
12. Characterization of [3H]ABT-418: a novel cholinergic channel ligand. Anderson DJ; Williams M; Pauly JR; Raszkiewicz JL; Campbell JE; Rotert G; Surber B; Thomas SB; Wasicak J; Arneric SP J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118 [TBL] [Abstract][Full Text] [Related]
13. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514 [TBL] [Abstract][Full Text] [Related]
14. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors. Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405 [TBL] [Abstract][Full Text] [Related]
16. Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line. Lukas RJ J Pharmacol Exp Ther; 1993 Apr; 265(1):294-302. PubMed ID: 8474012 [TBL] [Abstract][Full Text] [Related]
17. Site-selective photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor by azide derivatives of ethidium bromide. Pedersen SE Mol Pharmacol; 1995 Jan; 47(1):1-9. PubMed ID: 7838117 [TBL] [Abstract][Full Text] [Related]
18. Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors. Groebe DR; Gray WR; Abramson SN Biochemistry; 1997 May; 36(21):6469-74. PubMed ID: 9174364 [TBL] [Abstract][Full Text] [Related]
19. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants. Chiara DC; Xie Y; Cohen JB Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488 [TBL] [Abstract][Full Text] [Related]